TipRanks
Medicover AB (DE:5M0B)
FRANKFURT:5M0B
Germany Market
5M0B
Medicover AB
RESEARCH TOOLSreports

Medicover AB (5M0B) Ratios

0 Followers

Medicover AB Ratios

DE:5M0B's free cash flow for Q2 2026 was €0.24. For the 2026 fiscal year, DE:5M0B's free cash flow was decreased by € and operating cash flow was €0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.55 0.70 0.79 0.76 0.95
Quick Ratio
 0.48 0.61 0.67 0.64 0.78
Cash Ratio
 0.09 0.12 0.12 0.10 0.11
Solvency Ratio
 0.16 0.16 0.07 0.14 0.13
Operating Cash Flow Ratio
 0.35 0.49 0.46 0.41 0.48
Short-Term Operating Cash Flow Coverage
 0.66 1.32 1.47 1.29 4.02
Net Current Asset Value
€ -1.35B€ -1.38B€ -1.20B€ -1.03B€ -985.70M
Leverage Ratios
Debt-to-Assets Ratio
 0.60 0.59 0.58 0.52 0.51
Debt-to-Equity Ratio
 2.72 2.70 2.67 2.02 1.98
Debt-to-Capital Ratio
 0.73 0.73 0.73 0.67 0.66
Long-Term Debt-to-Capital Ratio
 0.42 0.54 0.54 0.45 0.50
Financial Leverage Ratio
 4.54 4.54 4.60 3.91 3.86
Debt Service Coverage Ratio
 0.64 1.09 0.70 1.20 2.74
Interest Coverage Ratio
 2.69 2.43 1.20 1.19 1.61
Debt to Market Cap
 0.26 0.29 0.29 0.28 0.28
Interest Debt Per Share
 10.07 9.98 8.64 7.06 6.55
Net Debt to EBITDA
 3.46 3.59 6.83 3.70 4.17
Profitability Margins
Gross Profit Margin
23.37%23.16%21.43%20.58%22.22%
EBIT Margin
7.07%6.83%3.50%4.29%3.58%
EBITDA Margin
16.01%15.88%8.18%14.74%14.30%
Operating Profit Margin
7.13%6.55%3.36%3.52%3.68%
Pretax Profit Margin
4.42%4.14%0.96%1.35%1.31%
Net Profit Margin
3.44%3.26%0.80%1.01%0.78%
Continuous Operations Profit Margin
3.26%3.06%0.70%1.05%0.91%
Net Income Per EBT
77.81%78.76%83.08%74.58%59.60%
EBT Per EBIT
61.98%63.20%28.59%38.44%35.68%
Return on Assets (ROA)
3.49%3.20%0.78%0.91%0.64%
Return on Equity (ROE)
16.01%14.55%3.59%3.54%2.49%
Return on Capital Employed (ROCE)
11.99%9.09%4.47%4.26%3.75%
Return on Invested Capital (ROIC)
6.28%5.59%2.79%2.87%2.48%
Return on Tangible Assets
5.26%4.82%1.13%1.32%0.98%
Earnings Yield
2.46%2.53%0.67%0.88%0.64%
Efficiency Ratios
Receivables Turnover
 6.68 6.97 9.85 9.88 9.20
Payables Turnover
 6.62 5.89 6.59 20.40 19.26
Inventory Turnover
 28.34 27.19 23.78 23.35 20.18
Fixed Asset Turnover
 2.42 2.27 2.14 1.99 1.80
Asset Turnover
 1.02 0.98 0.98 0.90 0.82
Working Capital Turnover Ratio
 -8.11 -14.38 -17.51 -25.37 14.51
Cash Conversion Cycle
 12.33 3.76 -2.98 34.69 38.82
Days of Sales Outstanding
 54.62 52.35 37.06 36.95 39.69
Days of Inventory Outstanding
 12.88 13.42 15.35 15.63 18.09
Days of Payables Outstanding
 55.17 62.02 55.39 17.89 18.96
Operating Cycle
 67.50 65.78 52.41 52.58 57.77
Cash Flow Ratios
Operating Cash Flow Per Share
 2.21 2.28 1.74 1.37 1.14
Free Cash Flow Per Share
 1.16 1.23 0.93 0.63 0.20
CapEx Per Share
 1.06 1.05 0.81 0.74 0.95
Free Cash Flow to Operating Cash Flow
 0.52 0.54 0.53 0.46 0.17
Dividend Paid and CapEx Coverage Ratio
 1.76 1.90 1.87 1.60 1.07
Capital Expenditure Coverage Ratio
 2.09 2.17 2.14 1.86 1.21
Operating Cash Flow Coverage Ratio
 0.23 0.24 0.21 0.20 0.18
Operating Cash Flow to Sales Ratio
 0.14 0.14 0.13 0.12 0.11
Free Cash Flow Yield
5.09%6.07%5.58%4.71%1.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.74 39.79 151.59 114.03 157.09
Price-to-Sales (P/S) Ratio
 1.39 1.29 1.20 1.15 1.23
Price-to-Book (P/B) Ratio
 6.44 5.74 5.39 4.04 3.90
Price-to-Free Cash Flow (P/FCF) Ratio
 19.66 16.48 17.93 21.24 62.62
Price-to-Operating Cash Flow Ratio
 10.31 8.90 9.56 9.79 10.89
Price-to-Earnings Growth (PEG) Ratio
 0.44 0.11 -18.19 2.37 -1.78
Price-to-Fair Value
 6.44 5.74 5.39 4.04 3.90
Enterprise Value Multiple
 12.17 11.69 21.45 11.50 12.75
Enterprise Value
 4.82B 4.42B 3.67B 2.96B 2.75B
EV to EBITDA
 12.17 11.69 21.45 11.50 12.75
EV to Sales
 1.95 1.86 1.76 1.69 1.82
EV to Free Cash Flow
 27.48 23.79 26.31 31.32 93.01
EV to Operating Cash Flow
 14.36 12.85 14.02 14.44 16.18
Tangible Book Value Per Share
 -1.73 -1.78 -1.12 -0.55 -0.75
Shareholders’ Equity Per Share
 3.54 3.54 3.10 3.32 3.19
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.27 0.22 0.29
Revenue Per Share
 16.32 15.78 13.93 11.69 10.15
Net Income Per Share
 0.56 0.51 0.11 0.12 0.08
Tax Burden
 0.78 0.79 0.83 0.75 0.60
Interest Burden
 0.62 0.61 0.27 0.31 0.37
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.16 0.17 0.04 0.13 0.03
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 3.26 3.49 13.03 8.69 8.60
Currency in EUR